Calidi Biotherapeutics, Inc.
Biotechnology company · San Diego, California, United States · NYSE: CLDI
Calidi Biotherapeutics, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2021. Its shares trade on NYSE under the ticker CLDI. It has reported private securities offerings to the US SEC, most recently $5.5 million sold in a notice filed in 2024.
Calidi Biotherapeutics at a glance
What does Calidi Biotherapeutics do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $5.5 million sold (2024).
Frequently asked questions about Calidi Biotherapeutics
Where is Calidi Biotherapeutics headquartered?
Calidi Biotherapeutics, Inc. is headquartered in San Diego, California, United States.
What does Calidi Biotherapeutics do?
Calidi Biotherapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Calidi Biotherapeutics a public company?
Yes. Calidi Biotherapeutics, Inc. trades on NYSE under the ticker CLDI.
When was Calidi Biotherapeutics founded?
The earliest incorporation on record for Calidi Biotherapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences